Jaime Espín
Impact in
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 43
- Pharmaceutical Economics and Policy 36
- Innovation Policy and R&D 8
- Healthcare Policy and Management 7
-
- Healthcare cost, quality, practices 8
- Co-authors
- David Epstein (8 shared papers)Emilio Sánchez‐Cantalejo (2 shared papers)Esther Molina‐Montes (2 shared papers)Joan Rovira (6 shared papers)María‐José Sánchez (2 shared papers)Leticia García‐Mochón (5 shared papers)Sabine Vogler (5 shared papers)Claudia Habl (2 shared papers)
- Journals
- Value in Health (9 papers)Cost Effectiveness and Resource Allocation (4 papers)The European Journal of Health Economics (4 papers)Journal of Pharmaceutical Policy and Practice (3 papers)Orphanet Journal of Rare Diseases (2 papers)
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Jaime Espín
62 papers receiving 768 citations
Peers
Comparison fields: 5 of 113
- Economics and Econometrics 411
- Applied Microbiology and Biotechnology 16
- Pharmacology 44
- Family Practice 11
- Cancer Research 74
Countries citing papers authored by Jaime Espín
This map shows the geographic impact of Jaime Espín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Espín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Espín more than expected).
Fields of papers citing papers by Jaime Espín
This network shows the impact of papers produced by Jaime Espín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Espín. The network helps show where Jaime Espín may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaime Espín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2020 | 71 | |
| 3 | 2014 | 57 | |
| 4 | 2021 | 35 | |
| 5 | 2019 | 28 | |
| 6 | 2009 | 28 | |
| 7 | 2022 | 24 | |
| 8 | 2010 | 24 | |
| 9 | 2013 | 24 | |
| 10 | The impact of biosimilars' entry in the EU market | 2014 | 24 |
| 11 | 2022 | 23 | |
| 12 | 2023 | 22 | |
| 13 | 2022 | 22 | |
| 14 | 2019 | 21 | |
| 15 | Short- and long-term effects of value-based pricingvs. external price referencing | 2010 | 21 |
| 16 | 2010 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2018 | 15 | |
| 19 | 2020 | 14 | |
| 20 | 2019 | 14 |
About Jaime Espín
Jaime Espín is a scholar working on Economics and Econometrics, General Health Professions, Immunology, Public Health, Environmental and Occupational Health and Sociology and Political Science, having authored 69 papers that have together received 794 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Pharmaceutical Economics and Policy (36 papers), Healthcare cost, quality, practices (8 papers), Biosimilars and Bioanalytical Methods (8 papers), Innovation Policy and R&D (8 papers), Healthcare Policy and Management (7 papers), Dermatology and Skin Diseases (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Economics and Econometrics (411 citations), Applied Microbiology and Biotechnology (16 citations), Pharmacology (44 citations), Family Practice (11 citations) and Cancer Research (74 citations). Jaime Espín has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include David Epstein, Emilio Sánchez‐Cantalejo, Esther Molina‐Montes, Joan Rovira, María‐José Sánchez, Leticia García‐Mochón, Sabine Vogler, Claudia Habl, Antonio Olry de Labry Lima and Juan Carlos Rejón-Parrilla. Their work appears in journals such as Value in Health, Cost Effectiveness and Resource Allocation, The European Journal of Health Economics, Journal of Pharmaceutical Policy and Practice and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.